AI risk in healthcare is not just a data problem. It can change care decisions.
I’d sum up the article this way: if you use AI in clinical or admin workflows, you need to track three linked stages of risk:
-
Stage 1: Reconnaissance and probing
Attackers map your models, APIs, prompts, and integrations. -
Stage 2: Prompt injection, manipulation, and poisoning
They try to change what the model sees or how it behaves. -
Stage 3: Data leakage, workflow compromise, and clinical harm
PHI can leak, workflows can fail, and patient care can be pushed off course.
The article’s main point is simple: you have the best chance to stop harm early. That starts with knowing which AI systems you have, what data they touch, who owns them, and where they connect into the EHR, PACS, HL7, and FHIR stack.
A few facts make the risk hard to ignore:
- About 133 million health records were compromised in 2023
- Healthcare ransomware incidents went from 214 in 2022 to 389 in 2023
- Email phishing drove about 63% of access-point breaches in 2024
- One 2025 study found prompt injection worked in 94.4% of trials against clinical LLMs and led to unsafe recommendations in 91.7% of high-harm cases
What should you do first?
- Build a clear AI inventory
- Log prompts, outputs, and query patterns
- Test for prompt injection and workflow abuse before deployment
- Lock down prompt changes, fine-tuning, and tool calls
- Review vendors for model, pipeline, and subprocessor risk
- Treat logs, embeddings, and vector stores as PHI when they can expose patient data
- Have rollback and manual fallback steps ready for AI incidents
The core idea: reconnaissance leads to manipulation, manipulation leads to leakage, and leakage can turn into patient harm.
So if I were reading this article for one takeaway, it would be this: AI security in healthcare has to cover the model, the data pipeline, and the clinical workflow - not just the network.
AI Kill Chain in Healthcare: 3 Stages from Reconnaissance to Clinical Harm
When AI Guardrails Become the Attack Vector | Why Healthcare AI Fails in Practice
sbb-itb-535baee
Stage 1: Reconnaissance, model inventory, and probing
Before any real attack starts, an adversary needs a map.
In the AI kill chain, that map comes from quietly figuring out which models a healthcare group uses, what data those models can touch, and where controls are thin. Reconnaissance often looks like normal traffic, which is what makes it hard to spot. Once an attacker has that map, they can use it as a starting point for manipulation in the next stage.
How attackers probe healthcare AI systems
Probing often begins with everyday prompts. An attacker may ask a clinical assistant the same question in slightly different ways and watch what happens. Do the answers shift? Does the model call a tool? Does it expose system instructions? They may also upload a file into a radiology workflow to test how the model handles outside content. Hidden prompt injections in imaging metadata or DICOM headers can steer vision-language models during routine radiology workflows.[2][5]
API probing works much the same way. Attackers test parameters, error messages, response timing, and rate limits. Bit by bit, those clues can show what the backend model can do, which EHR or PACS systems it talks to, and how authentication works. Because this activity can blend in with normal clinician or patient traffic, it may continue for days or weeks without setting off a standard alert. Good signals to watch include:
- Near-duplicate prompts
- High token volume from one user or IP
- Systematic prompt variation[4]
Why model inventory is the first line of defense
A full AI inventory is the first control. For each system, document the model, version, use case, owners, deployment environment, data sources, prompts, tools, and every EHR, PACS, HL7, or FHIR link. Record whether a human reviews outputs before they affect care, and spell out the patient impact if the model is wrong or manipulated.
The gaps often show up in the places teams miss: prompt libraries, retrieval-augmented generation knowledge bases, vendor-managed plugins, shadow AI tools used by clinicians, and downstream automations that act on model outputs. A scheduling chatbot tied to an undocumented EHR API, or a radiology triage model with retrieval sources that security doesn’t know about, gives an attacker a path defenders can’t see.
Each AI system should also have clear ownership. That means a named business owner, a clinical owner accountable for care quality, and a risk owner responsible for controls. That split matters because one system may shape documentation, triage, or imaging decisions at the same time. Ownership without clinical accountability leaves holes, and reconnaissance is built to find those holes.
Once the inventory is in place, teams are in a much better position to separate normal use from probing and respond faster when model manipulation starts.
How Censinet supports AI inventory and governance routing
Censinet RiskOps™ and Censinet AI centralize the AI inventory. Instead of living in a static spreadsheet, model and vendor information connects straight to governance workflows. That means findings go to the right people - security, compliance, clinical leadership, and the AI governance committee - with human review built in at each step.
When a new model is added or a vendor assessment reveals a gap, Censinet AI sends the related tasks and risk data to the designated owners automatically. In practice, the inventory becomes an active control. Security, compliance, and clinical leaders get routed findings, risk visibility, and PHI impact context, which helps keep the kill chain visible from reconnaissance through manipulation detection.
Stage 2: Prompt injection, model manipulation, and data poisoning
After reconnaissance and probing, attackers move into Stage 2 to change what the model sees and how it responds.
At this point, the goal is no longer just watching the system. It's active interference with model behavior and the data pipelines around it. In healthcare, that can lead to unsafe triage, misleading summaries, or weaker performance that opens the door to later abuse. Stage 2 also includes model manipulation, such as unauthorized fine-tuning, configuration changes, and system prompt edits. These attacks sit between early probing and later PHI leakage or clinical misuse.
Prompt injection and jailbreaks in clinical assistants and imaging workflows
Prompt injection uses hostile instructions to override model behavior.
In healthcare, that can happen in a few very ordinary-looking ways. A clinician might paste outside text into a documentation assistant. A patient might send a crafted message through a portal chatbot. Malicious text might also be tucked inside a clinical note that a summarization tool later pulls in.
The damage isn't limited to awkward text. It can alter care decisions.
Examples include:
- An EHR copilot omitting anticoagulation
- A triage chatbot downplaying chest pain
- A radiology assistant under-calling suspicious findings
In each case, the attack changes a decision point, not just a written response.
Indirect prompt injection is especially dangerous in retrieval-augmented generation (RAG) workflows. Here, the hostile instruction comes through a document, record, or outside content source instead of directly from a user. In RAG workflows, any ingested note, report, or faxed document can carry hidden instructions that the model may follow. And when the model can act on its own - calling EHR APIs, updating records, or sending messages - a successful injection can trigger real actions, not just misleading text.[1][7][8]
Once attackers can steer outputs, the next move is often to corrupt the data and pipelines that train or feed the model.
Data poisoning and model extraction across training and integration pipelines
Data poisoning targets the inputs that shape model behavior over time.
If an attacker alters HL7/FHIR messages, ETL feeds, or imaging labels, they can bias readmission models, hide abnormal labs, or make detection models miss specific findings. The scary part is that these changes may not be obvious right away. They quietly shape the setup for Stage 3 leakage and workflow abuse.
Model extraction is a related threat, and it often comes first. By systematically querying a clinical decision-support tool with varied synthetic scenarios and logging the outputs, an attacker can infer which symptom patterns trigger escalation, which combinations suppress an "ER recommended" response, and where thresholds sit for sepsis alerts or imaging prioritization. That knowledge can then be used to craft prompt injections or adversarial inputs that exploit specific weak spots. It also gives attackers a clearer view of the workflow layer targeted in Stage 3.
Controls for manipulation: red-teaming, access control, and vendor due diligence
Cutting Stage 2 risk takes layers of control, not one magic fix.
AI red-teaming in healthcare should include clinical subject-matter experts working with security and data science teams. The testing should use realistic cases - chest pain, stroke symptoms, and oncology follow-up, for example - to see whether injected instructions can override safety guardrails or produce clinically unsafe outputs.[6] Teams should also test workflow-embedded content, including hostile instructions placed in EHR problem lists, imaging report templates, or patient messages, to make sure AI assistants don't treat that content as more authoritative than system prompts.
Access control matters just as much. Only a small, vetted group should be able to modify system prompts, fine-tuning parameters, or safety policies. Those changes should sit behind role-based access control, with audit trails for every update. Staging environments should use de-identified data wherever HIPAA guidance permits. Integration endpoints that feed AI pipelines - HL7/FHIR interfaces, ETL jobs, and imaging feeds - should use allowlists and mutual authentication to block unauthorized data sources. And for systems that can act on their own, tool-call allowlists and human-in-the-loop confirmation for high-impact actions like ordering tests, changing medications, or sending bulk messages are key guardrails.
Vendor due diligence also needs to go past a general security checklist. Security and compliance teams should ask vendors how they separate system and user prompts, what controls exist on training and fine-tuning pipelines, how they detect anomalous query patterns that may point to extraction attempts, and who their subprocessors are. Censinet AI™ can help by automatically summarizing vendor security and AI governance documentation, extracting details about safeguards, integration architectures, and fourth-party dependencies, and mapping those findings to internal risk controls so leaders can quickly see where a vendor is exposed on Stage 2 controls.
| Attack Type | Preventive Controls | Detective Controls |
|---|---|---|
| Prompt injection / jailbreak | Separate system and user prompts, input classifiers, tool-call allowlists, conversation caps, human-in-the-loop review for high-impact actions | Output safety filters, flagged-output review |
| Data poisoning | ETL allowlists, mutual authentication on data feeds, data quality checks, staging/production separation | Data lineage audits, anomaly checks |
| Model extraction | API rate limiting, query pattern controls, access tiering for CDS tools | High-volume query alerts, query review |
Weak controls at this stage often become the entry point for PHI leakage and clinical workflow compromise.
Stage 3: Data leakage, workflow compromise, and clinical exploitation
Stage 3 is where model abuse turns into a direct patient-safety problem. PHI leaks. Workflows break. Care gets pushed in the wrong direction. Once an attacker can steer prompts or poison inputs, the next step is often data exposure or unsafe care.
How PHI and sensitive clinical data leak from AI systems
PHI can leak through AI-specific paths that slip past standard controls. For example, a clinician might paste a full consult note into an AI documentation assistant, and that prompt could be sent to a third-party model without a proper business associate agreement (BAA). A radiology AI might store imaging report embeddings in a shared vector database, and one bad setting could let another tenant's app rebuild parts of those reports. Or AI interaction logs might sit in plaintext inside a monitoring platform that vendor engineers can access. At that point, those logs become yet another PHI-bearing asset. [12][13][16][17][23]
LLMs can also memorize training data. So if an organization fine-tunes a model on ED notes without de-identification, the model may reproduce rare patient narratives when prompted in the right way. [12][15][18][20] Recent guidance more and more treats embeddings derived from PHI as PHI themselves, because text can be partly reconstructed from them. [20][23]
Under HIPAA's Security and Privacy Rules, these are not minor technical misses. They can turn into breach-notification events. Every AI component and vendor that touches PHI, including logs, vector stores, and monitoring dashboards, needs to be mapped, governed, and covered by the right BAAs and access controls. [9][12][14][17][19][22][23]
How compromised AI workflows can affect care delivery
If leakage doesn't stop the attack, the same compromise can move straight into care delivery.
Clinical harm from AI compromise often starts quietly. A 2025 study found prompt injection succeeded in 94.4% of trials against clinical LLMs and led to unsafe recommendations in 91.7% of high-harm scenarios. [3]
In intraoperative support models, full-duration visual prompt injection dropped accuracy from 0.67 to 0.24. That kind of drop can mean missed bleeding, foreign objects, or polyps. [10][11]
At the workflow level, the damage can look mundane at first glance, which is part of what makes it dangerous. An AI scheduler can cancel high-priority procedures. An AI scribe can leave out allergy history or suicide-risk history. Then the ripple effects start: backlogs, missed follow-up, and billing errors downstream. [16][17][21]
Monitoring, logging, and incident response for AI-driven clinical risk
Detection matters only if it leads to fast containment.
Teams should monitor prompts, outputs, telemetry, drift, safety-filter activations, and workflow anomalies across EHR, order-entry, and scheduling systems. Those are the same signals created by the prompt, output, and workflow abuse described in Stages 1 and 2. [14][17][19][22][23]
Full prompt and output logging can help operations, but it also creates a PHI-bearing asset. That means it needs encryption, role-based access, set retention periods, and secure deletion. A practical middle ground is to use sampling, de-identification, or hashing so teams can spot patterns without storing identifiable content. [14][17][19][22][23]
Urgent AI incidents should be routed to security, privacy, clinical leadership, and the AI governance team. From there, the immediate move is simple: roll back to a known-safe model version and switch to manual fallback workflows.
| Late-Stage Attack Outcome | Containment Action | Response Action |
|---|---|---|
| PHI exposed via AI output or log | Restrict AI feature access; isolate affected AI component | Breach risk assessment; notify privacy officer; evaluate HITECH notification |
| Unsafe CDS recommendation delivered | Disable or sandbox affected CDS tool; alert clinical leadership | Clinical review of affected orders; root cause analysis; vendor escalation |
| Triage model under-ranking high-acuity complaints | Revert to manual triage protocols; isolate model version | Audit affected patient encounters; notify CMIO and risk management |
| Scheduling disruption via AI manipulation | Suspend AI scheduling; restore manual queue | Assess patient impact; review vendor access logs; update incident runbook |
| Workflow anomaly (documentation gaps, order spikes) | Flag affected records; pause AI-assisted documentation | Clinical audit; model performance review; governance escalation |
Building a continuous AI risk program: control mapping and next steps
A control map for the full AI kill chain
Those containment steps only work when they live inside one continuous program. The three stages in this guide need one connected control program, not three separate tracks. The table below links the AI kill chain to the controls already covered in this guide.
| Kill Chain Stage | Representative Clinical Systems | Key Controls |
|---|---|---|
| Reconnaissance & Probing | Patient-facing chatbots, symptom checkers, API-integrated CDS | Model inventory, endpoint controls, rate limits, prompt/query logging |
| Prompt Injection & Manipulation | Radiology decision support, OR scheduling assistants, LLM-integrated EHR tools | Pre-deployment red-teaming, prompt guardrails, vendor due diligence |
| Data Leakage & Exploitation | Generative documentation tools, transcription services, imaging analysis platforms | PHI classification, DLP, centralized logging, incident runbooks |
The weak spot sits upstream: inventory, governance, and risk analysis. Under NIST CSF 2.0, Identify and Govern both reached 64% coverage, while Respond hit 85%.[24] That shortfall in governance is what lets threats move from reconnaissance to manipulation and then to exploitation without being stopped.
Proposed HIPAA Security Rule updates would also require AI systems that handle ePHI to be listed in asset inventories and go through risk analysis at least every 12 months, and whenever new AI is adopted.[25]
How Censinet serves as the operating layer for AI risk management
This control map works only if findings, owners, and remediation tasks move through a single workflow. Censinet RiskOps™ acts as a central hub for AI-related policies, risks, and tasks. Its AI governance routing sends assessment findings and remediation work to the right stakeholders, including AI governance committee members, so issues land with the right owner instead of bouncing around.
That routing supports the full chain:
- Inventory visibility for reconnaissance
- Vendor review for manipulation risk
- Logging and incident routing for leakage and exploitation
Censinet AI™ also speeds vendor assessments by summarizing evidence, capturing fourth-party risk, and generating risk reports. Human reviewers still make the final call; automation just moves the work along faster.
Key takeaways for security, compliance, and clinical leaders
AI threats in healthcare are linked, not isolated. Reconnaissance feeds manipulation. Manipulation drives leakage. Leakage turns into clinical harm. That’s why inventory and governance need to come first. If you don’t know which AI systems are in use, where they connect, and what data they touch, protection and detection become guesswork.
Red-teaming and vendor due diligence should happen before deployment, not after. Then the job shifts to continuous monitoring across prompts, outputs, model drift, and workflow anomalies so teams can spot exploitation early and contain it before patient harm.
FAQs
What is the AI kill chain in healthcare?
The AI kill chain in healthcare is the step-by-step path attackers follow to break into an AI system and affect clinical care.
It usually starts with model reconnaissance, plus prompt or API probing. From there, attackers move to model manipulation, then to data leakage or workflow compromise, and finally to clinical exploitation that can disrupt care delivery and put patient safety at risk.
Which AI systems should we inventory first?
Put AI systems in order based on how much they could affect patient safety and data security. Start with high-risk use cases like sepsis detection, clinical imaging triage, medication decision support, and discharge planning.
Also document any AI components that handle PHI, including models, datasets, APIs, and supporting infrastructure. Pay close attention to autonomous workflows that can influence care delivery without human oversight.
How can AI attacks affect patient care?
AI attacks can hit patient care in direct, immediate ways. They can skew medical decisions, interrupt time-sensitive services, and expose private health data.
That can lead to diagnostic mistakes, unsafe treatment suggestions, and breakdowns in day-to-day workflows like scheduling, lab coordination, and organ allocation. And if AI systems or outside vendors are breached or go offline, clinicians may lose access to the devices or decision support tools that patients depend on.